Observational Study of Rapid Sequence Intubation (RSI) Drug Delivery Using Intraosseous (IO) and Intravenous (IV) Access.

January 31, 2013 updated by: Vidacare Corporation

An Observational Study of Intubating Conditions Comparing Intraosseous Vascular Access With Peripheral Intravenous Access for Drug Delivery in Rapid Sequence Intubation

This study will evaluate using intraosseous vascular access and intravenous vascular access to give patients the necessary medications to perform rapid sequence intubation, for patients with airway difficulties. The investigators think the device operator will find the intraosseous and intravenous routes equal for drug delivery.

Study Overview

Status

Terminated

Conditions

Detailed Description

This observational study will evaluate the intubating conditions of patients receiving rapid sequence intubation when receiving paralytic drug delivery via intravenous or intraosseous vascular access from the perspective of the medical professional performing rapid sequence intubation. The investigators believe that medical professionals will find equal intubating conditions for intravenous and intraosseous drug delivery.

Study Type

Observational

Enrollment (Actual)

2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Corpus Christi, Texas, United States, 78405
        • Christus Spohn Hospital Corpus Christi
      • El Paso, Texas, United States, 79905
        • Texas Tech University Health Science Center El Paso

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients in the emergency department with airway difficulties requiring rapid sequence intubation.

Description

Inclusion Criteria:

  • Requires rapid sequence intubation
  • Succinylcholine is chosen paralytic agent
  • IV or IO access has been established for rapid sequence intubation
  • For IV access patients, their rapid sequence intubation case is the next occurring IV rapid sequence intubation case following an enrolled IO RSI case.

Exclusion Criteria:

  • Vascular access other than IV or IO has been established

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intravenous (IV) drug delivery
patients on whom intravenous vascular access has been established for the purpose of rapid sequence intubation drug delivery.
Intraosseous (IO) drug delivery
Patients on whom intraosseous vascular access has been established for rapid sequence intubation drug delivery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Time from first drug delivery to operator-perceived sufficient relaxation to perform endotracheal tube placement
Time Frame: during rapid sequence intubation procedure, average expected time frame 30 minutes
during rapid sequence intubation procedure, average expected time frame 30 minutes
Intubation difficulty using the intubation difficulty scale
Time Frame: during rapid sequence intubation procedure, average expected time frame 30 minutes
during rapid sequence intubation procedure, average expected time frame 30 minutes
Operator satisfaction with intubating conditions using visual analog scale
Time Frame: during rapid sequence intubation procedure, average expected time frame 30 minutes
during rapid sequence intubation procedure, average expected time frame 30 minutes
Failure rate of endotracheal intubation and requirement for alternative airway management methods
Time Frame: during rapid sequence intubation procedure, average time frame 30 minutes
during rapid sequence intubation procedure, average time frame 30 minutes

Secondary Outcome Measures

Outcome Measure
Time Frame
Incidence of short-term catheter related complications for each technique
Time Frame: during emergency department stay, average time frame 24 hours
during emergency department stay, average time frame 24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Stephen W Borron, MD, Texas Tech University Health Science Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2012

Primary Completion (Actual)

December 1, 2012

Study Completion (Actual)

December 1, 2012

Study Registration Dates

First Submitted

December 2, 2011

First Submitted That Met QC Criteria

December 5, 2011

First Posted (Estimate)

December 6, 2011

Study Record Updates

Last Update Posted (Estimate)

February 1, 2013

Last Update Submitted That Met QC Criteria

January 31, 2013

Last Verified

January 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • 2011-13 (ICIRC)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Airway Control

3
Subscribe